CELGENE CORP Contracts & Agreements

154 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Assignment, Assumption and Amendment Agreement among Celgene Corporation, Bristol-Myers Squibb Company, American Stock Transfer & Trust Company, and Equiniti Trust Company...
Assignment Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
Asset Purchase Agreement between Celgene Corporation and Amgen Inc. dated August 25, 2019
Purchase Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture to Indenture Dated October 7, 2010 by Celgene Corporation and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture to 2012 Indenture between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture to 2013 Indenture between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture to 2014 Indenture between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture to Indenture Dated August 12, 2015 between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture to 2017 Indenture between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture to Indenture Dated November 9, 2017 between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture to Indenture Dated February 20, 2018 between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
Celgene Corporation Executive Severance Plan (Effective December 17, 2018)
Severance Agreements
CELGENE CORP
Pharmaceuticals
DE
2019
Celgene Employment Offer Letter for President, Clinical Development
Employment Agreements
CELGENE CORP
Pharmaceuticals
2018
Celgene Executive Vice President and Chief Financial Officer Employment Offer Letter – David V. Elkins
Employment Agreements
CELGENE CORP
Pharmaceuticals
2018
$2,000,000,000 Amended and Restated Credit Agreement among Celgene Corporation, Initial Lenders, and Citibank, N.A.
Credit Agreements
CELGENE CORP
Pharmaceuticals
DE
2018
Indenture Agreement between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A. dated February 20, 2018
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Celgene Corporation 2.875% Senior Note Due 2021 (Form of Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Celgene Corporation 3.250% Senior Note due 2023 (Global Security Form)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Celgene Corporation 3.900% Senior Note Due 2028 (Form of Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Celgene Corporation 4.550% Senior Note Due 2048 (Global Security Form)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Celgene Corporation $4.5 Billion Senior Notes Underwriting Agreement with Underwriters (February 2018)
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Celgene Corporation and The Bank of New York Mellon Trust Company, N.A. Indenture Dated November 9, 2017
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Celgene Corporation 2.750% Senior Note due 2023 (Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Celgene Corporation 3.450% Senior Note due 2027 (Global Security Form)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Celgene Corporation 4.350% Senior Note Due 2047 (Global Security Form)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Celgene Corporation $3 Billion Senior Notes Underwriting Agreement with Underwriters (2017)
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Amendment No. 3 to Second Amended and Restated Credit Agreement among Celgene Corporation, Citibank, N.A., and Lenders
Credit Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Celgene Corporation Stock Option Agreement under 2008 Stock Incentive Plan (Amended & Restated)
Warrant Agreements
CELGENE CORP
Pharmaceuticals
2017
Celgene Corporation Restricted Stock Unit Agreement for US Employees under 2008 Stock Incentive Plan
Stock Agreements
CELGENE CORP
Pharmaceuticals
2017
Celgene Corporation Performance Stock Unit Agreement under 2008 Stock Incentive Plan (Amended and Restated)
Stock Agreements
CELGENE CORP
Pharmaceuticals
2017
Amendment to Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015)
Stock Agreements
CELGENE CORP
Pharmaceuticals
2016
First Amendment to Second Amended and Restated Credit Agreement among Celgene Corporation, Citibank, N.A., and Lenders
Credit Agreements
CELGENE CORP
Pharmaceuticals
NY
2016
Amendment No. 2 to Second Amended and Restated Credit Agreement among Celgene Corporation, Lenders, and Citibank, N.A.
Credit Agreements
CELGENE CORP
Pharmaceuticals
NY
2016
Amendment No. 3 to Amended and Restated Employment Agreement between Celgene Corporation and Robert J. Hugin
Employment Agreements
CELGENE CORP
Pharmaceuticals
2016
Amendment No. 4 to Amended and Restated Employment Agreement between Celgene Corporation and Robert J. Hugin
Employment Agreements
CELGENE CORP
Pharmaceuticals
2016
Revolving Credit Agreement between Celgene Corporation and JPMorgan Chase Bank, N.A. dated August 25, 2015
Credit Agreements
CELGENE CORP
Pharmaceuticals
2015
Celgene Corporation and The Bank of New York Mellon Trust Company, N.A. Indenture Dated August 12, 2015
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Celgene Corporation 2.125% Senior Note Due 2018 (Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Celgene Corporation 2.875% Senior Note Due 2020 (Form of Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Celgene Corporation 3.550% Senior Note Due 2022 (Global Security Form)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Celgene Corporation 3.875% Senior Note Due 2025 (Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Celgene Corporation 5.000% Senior Note due 2045 (Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Celgene Corporation $8 Billion Senior Notes Underwriting Agreement with Underwriters (August 3, 2015)
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Celgene Corporation $5 Billion Bridge Loan Facility Commitment Letter with JPMorgan Chase Bank, N.A. and J.P. Morgan Securities LLC (Project Strix)
Facility Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Second Amended and Restated Credit Agreement among Celgene Corporation, Initial Lenders, and Citibank, N.A.
Credit Agreements
CELGENE CORP
Pharmaceuticals
DE
2015
Indenture Agreement between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A. (May 15, 2014)
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
Celgene Corporation 4.625% Senior Note Due 2044 (Form of Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
Indenture Agreement between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A. dated August 6, 2013
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2013
Indenture Agreement between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A. dated August 9, 2012
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2012
$1,000,000,000 Credit Agreement among Celgene Corporation, Initial Lenders, and Citibank, N.A. (September 2, 2011)
Credit Agreements
CELGENE CORP
Pharmaceuticals
DE
2011
Indenture Agreement between Celgene Corporation and The Bank of New York Mellon Trust Company, N.A. dated October 7, 2010
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2010
Non-Competition, Non-Solicitation and Confidentiality Agreement between Dr. Patrick Soon-Shiong and Celgene Corporation
Non-Competition Agreements
CELGENE CORP
Pharmaceuticals
CA
2010
Stockholders’ Agreement between Celgene Corporation and Abraxis BioScience, Inc. Stockholders (June 30, 2010)
Shareholders Agreements
CELGENE CORP
Pharmaceuticals
DE
2010
Amendment No. 2 to Amended and Restated Employment Agreement between Celgene Corporation and Sol J. Barer
Employment Agreements
CELGENE CORP
Pharmaceuticals
2010
Amendment No. 2 to Amended and Restated Employment Agreement between Celgene Corporation and Robert J. Hugin
Employment Agreements
CELGENE CORP
Pharmaceuticals
2010
Amendment No. 1 to Amended and Restated Employment Agreement between Celgene Corporation and Sol J. Barer
Employment Agreements
CELGENE CORP
Pharmaceuticals
2009
Amendment No. 1 to Amended and Restated Employment Agreement between Celgene Corporation and Robert J. Hugin
Employment Agreements
CELGENE CORP
Pharmaceuticals
2009
Employment Agreement between Celgene International Sàrl and Mr. Aart Brouwer
Employment Agreements
CELGENE CORP
Pharmaceuticals
2009
Addendum and Assignment of Swiss Employment Contract between Aart Brouwer and Celgene Management Sàrl
Employment Agreements
CELGENE CORP
Pharmaceuticals
2009
Employment Agreement between Celgene International Sàrl and Aart Brouwer (President International)
Employment Agreements
CELGENE CORP
Pharmaceuticals
2008
Employment Letter Agreement and Amendment between Celgene Corporation and Dr. Graham Burton
Employment Agreements
CELGENE CORP
Pharmaceuticals
2008
Amendment to Employment Letter Agreement between Celgene Corporation and David Gryska (April 28, 2008)
Employment Agreements
CELGENE CORP
Pharmaceuticals
2008
Supplemental Indenture to 1.75% Convertible Notes Due 2008 between Celgene Corporation and The Bank of New York
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2008
Celgene Offer Letter for Senior Vice President & Chief Financial Officer to David Gryska
Employment Agreements
CELGENE CORP
Pharmaceuticals
2007
Celgene Offer Letter for Chief Financial Officer Position – David Gryska
Employment Agreements
CELGENE CORP
Pharmaceuticals
2007
Celgene Corporation Underwriting Agreement for 20,000,000 Shares of Common Stock with Merrill Lynch & J.P. Morgan (2006)
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2006
Amended and Restated Employment Agreement between Celgene Corporation and Sol J. Barer (May 1, 2006)
Employment Agreements
CELGENE CORP
Pharmaceuticals
NJ
2006
Amended and Restated Employment Agreement between Celgene Corporation and Robert J. Hugin
Employment Agreements
CELGENE CORP
Pharmaceuticals
NJ
2006
Amended and Restated Distribution Services and Storage Agreement between Celgene Corporation and Sharp Corporation (2005)
Distribution Agreements
CELGENE CORP
Pharmaceuticals
NJ
2006
Amendment No. 2 to Amended and Restated Distribution and License Agreement between Pharmion GmbH and Celgene UK Manufacturing II Limited
Distribution Agreements
CELGENE CORP
Pharmaceuticals
2005
Amended and Restated Employment Agreement between Celgene Corporation and John W. Jackson
Employment Agreements
CELGENE CORP
Pharmaceuticals
NJ
2004
Amended and Restated Employment Agreement between Celgene Corporation and Sol J. Barer (May 1, 2003)
Employment Agreements
CELGENE CORP
Pharmaceuticals
NJ
2004
Amended and Restated Employment Agreement between Celgene Corporation and Robert J. Hugin
Employment Agreements
CELGENE CORP
Pharmaceuticals
NJ
2004
Distribution and Supply Agreement between SmithKline Beecham Corporation (GlaxoSmithKline) and Celgene Corporation dated March 31, 2003
Distribution Agreements
CELGENE CORP
Pharmaceuticals
NJ
2003
Contingent Value Rights Agreement by and between Bristol-Myers Squibb Company and Trustee (Celgene Merger)
CELGENE CORP
Pharmaceuticals
NY
2019
Agreement and Plan of Merger among Bristol-Myers Squibb Company, Burgundy Merger Sub, Inc., and Celgene Corporation (January 2, 2019)
Merger Agreements
CELGENE CORP
Pharmaceuticals
DE
2019
Agreement and Plan of Merger among Juno Therapeutics, Inc., Celgene Corporation, and Blue Magpie Corporation (January 21, 2018)
Merger Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Celgene Corporation 2017 Stock Incentive Plan (Amended and Restated as of April 19, 2017)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
DE
2017
Celgene Corporation Compensation and Severance Letter Agreement with Scott Smith (President and COO)
Compensation Agreements
CELGENE CORP
Pharmaceuticals
2017
Letter Agreement Regarding Compensation Package for S.J. Rupert Vessey with Celgene Corporation
Compensation Agreements
CELGENE CORP
Pharmaceuticals
2017
Letter Agreement Regarding 2015 Compensation Package for Scott A. Smith with Celgene Corporation
Compensation Agreements
CELGENE CORP
Pharmaceuticals
2015
Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
DE
2015
Agreement and Plan of Merger among Celgene Corporation, Strix Corporation, and Receptos, Inc. (July 14, 2015)
Merger Agreements
CELGENE CORP
Pharmaceuticals
DE
2015
Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
DE
2015
License Agreement between Nogra Pharma Limited and Celgene Corporation/Celgene Alpine Investment Company II LLC (April 23, 2014)
License Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
Amendment No. 1 to Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2014
Celgene Corporation 2.250% Senior Note Due 2019 (Form of Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
Celgene Corporation 3.625% Senior Note Due 2024 (Form of Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
Celgene Corporation $2.5 Billion Senior Notes Underwriting Agreement with Underwriters (May 6, 2014)
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
Celgene Corporation Management Incentive Plan (MIP) for Plan Year 2013
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2014
Celgene Corporation 2.300% Senior Note Due 2018 (Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2013
Celgene Corporation 4.000% Senior Note Due 2023 (Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2013
Celgene Corporation 5.250% Senior Note Due 2043 (Global Security Form)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2013
Celgene Corporation $1.5 Billion Senior Notes Underwriting Agreement (2013)
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2013
Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
DE
2013
2013 Compensation Agreement between Celgene Corporation and Mark Alles
Compensation Agreements
CELGENE CORP
Pharmaceuticals
2013
2013 Compensation Package Summary Agreement between Celgene Corporation and Thomas Daniel
Compensation Agreements
CELGENE CORP
Pharmaceuticals
2013
2013 Compensation Agreement between Celgene Corporation and Perry Karsen, EVP and COO
Compensation Agreements
CELGENE CORP
Pharmaceuticals
2013
Amended and Restated $1.5 Billion Credit Agreement among Celgene Corporation, Citibank, N.A., and Initial Lenders (April 18, 2013)
Credit Agreements
CELGENE CORP
Pharmaceuticals
DE
2013
Celgene Corporation 2012 Management Incentive Plan (MIP)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2013
Celgene Corporation Stock Option Agreement Under 2008 Stock Incentive Plan (Amended and Restated June 17, 2009)
Stock Agreements
CELGENE CORP
Pharmaceuticals
2013
Celgene Corporation Restricted Stock Unit Agreement under 2008 Stock Incentive Plan (US Employees)
Stock Agreements
CELGENE CORP
Pharmaceuticals
2013
Celgene Corporation 1.900% Senior Notes Due 2017 (Form of Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2012
Celgene Corporation 3.250% Senior Notes Due 2022 (Form of Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2012
Underwriting Agreement for $1.5 Billion Senior Notes between Celgene Corporation and Underwriters (August 6, 2012)
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2012
Amendment No. 2 to the Celgene Corporation 2008 Stock Incentive Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2012
Amendment No. 1 to the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of June 17, 2009)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2011
Celgene Corporation 2.450% Senior Note Due 2015 (Global Security Form)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2010
Celgene Corporation 3.950% Senior Note Due 2020 (Global Security Form)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2010
Celgene Corporation 5.700% Senior Note due 2040 (Global Security)
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2010
Celgene Corporation $1.25 Billion Senior Notes Underwriting Agreement (2010)
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2010
Agreement and Plan of Merger among Celgene Corporation, Artistry Acquisition Corp., and Abraxis BioScience, Inc. (June 30, 2010)
Merger Agreements
CELGENE CORP
Pharmaceuticals
NY
2010
Contingent Value Rights Agreement between Celgene Corporation and Trustee (2010)
CELGENE CORP
Pharmaceuticals
NY
2010
Voting Agreement among Celgene Corporation, Artistry Acquisition Corp., and Abraxis BioScience Stockholders (June 30, 2010)
Voting Agreements
CELGENE CORP
Pharmaceuticals
DE
2010
Services Agreement between Celgene Corporation and Sol J. Barer (April 28, 2010)
Services Agreements
CELGENE CORP
Pharmaceuticals
NJ
2010
Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of June 17, 2009)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
DE
2009
Amendment Number Six to Celgene Corporation 1995 Non-Employee Directors’ Incentive Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2008
Celgene Corporation 2008 Stock Incentive Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
DE
2008
Celgene Corporation 2005 Deferred Compensation Plan (Amended and Restated Effective January 1, 2008)
Compensation Agreements
CELGENE CORP
Pharmaceuticals
NJ
2008
Agreement and Plan of Merger among Celgene Corporation, Cobalt Acquisition LLC, and Pharmion Corporation (November 18, 2007)
Merger Agreements
CELGENE CORP
Pharmaceuticals
DE
2007
Voting Agreement between Pharmion Corporation Stockholder and Celgene Corporation
Voting Agreements
CELGENE CORP
Pharmaceuticals
2007
Amendment No. 3 to Celgene Corporation 1998 Stock Incentive Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2007
Amendment Number Five to Celgene Corporation 1995 Non-Employee Directors’ Incentive Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2007
Asset Purchase Agreement between Siegfried Ltd., Siegfried Dienste AG, and Celgene Chemicals Sarl. dated December 8, 2006
Purchase Agreements
CELGENE CORP
Pharmaceuticals
2007
Celgene Corporation 2006 Management Incentive and Performance Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2007
Celgene Corporation 1998 Stock Incentive Plan (Amended and Restated as of April 23, 2003)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
DE
2006
Amendment No. 2 to the Celgene Corporation 1998 Stock Incentive Plan (Amended and Restated as of April 23, 2003 and as Further Amended)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2006
Celgene Corporation and John W. Jackson Services Agreement (May 1, 2006)
Services Agreements
CELGENE CORP
Pharmaceuticals
NJ
2006
License Agreement between Celgene Corporation and Pharmion GmbH (with Guaranty by Pharmion Corporation)
License Agreements
CELGENE CORP
Pharmaceuticals
DE
2006
Amendment No. 1 to License Agreement among Pharmion GmbH, Pharmion Corporation, and Celgene Corporation
License Agreements
CELGENE CORP
Pharmaceuticals
NY
2006
Amendment Agreement to License and Letter Agreement between Pharmion Corporation, Pharmion GmbH, and Celgene Corporation
Modification Agreements
CELGENE CORP
Pharmaceuticals
2006
Amendment No. 2 to License Agreement among Pharmion GmbH, Pharmion Corporation, and Celgene Corporation
License Agreements
CELGENE CORP
Pharmaceuticals
NY
2006
Second Amendment to License Agreement between Pharmion Corporation, Pharmion GmbH, and Celgene Corporation
Modification Agreements
CELGENE CORP
Pharmaceuticals
2006
Supply Agreement between Celgene Corporation and Evotec OAI Limited for Manufacture of CC-5013
Supply Agreements
CELGENE CORP
Pharmaceuticals
NJ
2006
Commercial Contract Manufacturing Agreement between OSG Norwich Pharmaceuticals, Inc. and Celgene Corporation (April 26, 2004)
Supply Agreements
CELGENE CORP
Pharmaceuticals
NY
2006
Finished Goods Supply Agreement between Penn Pharmaceutical Services Limited and Celgene Corporation (Revlimid)
Supply Agreements
CELGENE CORP
Pharmaceuticals
NJ
2006
Amendment Number Three to Celgene Corporation 1995 Non-Employee Directors' Incentive Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2005
Celgene Corporation 2005 Deferred Compensation Plan
Compensation Agreements
CELGENE CORP
Pharmaceuticals
NJ
2005
Technical Services Agreement between Penn Pharmaceutical Services Limited, Penn T Limited, Celgene Corporation, and Penn Pharmaceuticals Holdings Limited (October 21, 2004)
Services Agreements
CELGENE CORP
Pharmaceuticals
DE
2005
Amendment to S.T.E.P.S. License Agreement between Celgene Corporation, Pharmion Corporation, and Pharmion GmbH
License Agreements
CELGENE CORP
Pharmaceuticals
2005
Amendment to License Agreement between Celgene Corporation, Pharmion Corporation, and Pharmion GmbH (December 3, 2004)
License Agreements
CELGENE CORP
Pharmaceuticals
2005
Thalomid Clinical Development and Funding Agreement between Pharmion and Celgene (2005-2007)
Development Agreements
CELGENE CORP
Pharmaceuticals
2005
Sublease Agreement between Gateway, Inc. and Celgene Corporation for 4550 Towne Centre Court, San Diego
Lease Agreements
CELGENE CORP
Pharmaceuticals
2005
Purchase and Sale Agreement between Ticona LLC and Celgene Corporation for Summit, NJ Property
Purchase Agreements
CELGENE CORP
Pharmaceuticals
2004
Exclusive License Agreement among Celgene Corporation, Children's Medical Center Corporation, and EntreMed, Inc.
License Agreements
CELGENE CORP
Pharmaceuticals
MA
2003
Supply Agreement between SIFAVITOR S.p.A. and Celgene Corporation for Bulk Thalidomide
Supply Agreements
CELGENE CORP
Pharmaceuticals
2003
Siegfried Supply Agreement between Siegfried (USA), Inc. and Celgene Corporation (January 1, 2003)
Supply Agreements
CELGENE CORP
Pharmaceuticals
NJ
2003
Anthrogenesis Corporation Qualified Employee Incentive Stock Option Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2003
Amendment Number One to the Celgene Corporation 1992 Long-Term Incentive Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2002
Amendment Number One to the Celgene Corporation 1995 Non-Employee Directors' Incentive Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2002
Amendment Number Two to the Celgene Corporation 1995 Non-Employee Directors' Incentive Plan
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2002
Amendment to Celgene Corporation 1998 Long-Term Incentive Plan (June 18, 2002)
Bonus & Incentive Agreements
CELGENE CORP
Pharmaceuticals
2002
Exclusive Patent License and Termination Agreement among Children's Medical Center Corporation, Celgene Corporation, BioVenture Investments KFT, and EntreMed, Inc.
License Agreements
CELGENE CORP
Pharmaceuticals
MA
2002
Development and License Agreement between Celgene Corporation and Novartis Pharma AG (April 19, 2000)
License Agreements
CELGENE CORP
Pharmaceuticals
NY
2001
Collaborative Research and License Agreement between Novartis Pharma AG and Celgene Corporation
License Agreements
CELGENE CORP
Pharmaceuticals
NY
2001